Share Price and Basic Stock Data
Last Updated: January 24, 2026, 3:36 pm
| PEG Ratio | 0.93 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alembic Ltd, operating in the realty sector, reported a current price of ₹91.2 and a market capitalization of ₹2,342 Cr. The company’s revenue from operations has shown a positive trajectory, with sales increasing from ₹127 Cr in FY 2023 to ₹222 Cr in FY 2025, indicating a robust growth strategy. Quarterly sales figures also reflect this trend, with the latest reported sales for June 2025 at ₹60 Cr and a forecast for September 2025 to reach ₹56 Cr. The operating profit margin (OPM) stood at a commendable 42%, showcasing operational efficiency. The company has been able to maintain sales between ₹31 Cr and ₹39 Cr in the last quarters of 2023, suggesting stability. The reported total assets as of March 2025 were ₹2,503 Cr, which further supports Alembic’s growth narrative in the real estate sector, a market presently buoyed by government policies and infrastructure developments.
Profitability and Efficiency Metrics
Alembic Ltd’s profitability metrics demonstrate strong operational performance, with a net profit of ₹311 Cr in FY 2025, an increase from ₹269 Cr in FY 2024. The net profit margin stood at 65.15% for FY 2025, reflecting a high level of profitability compared to typical sector margins. The operating profit for the same period was ₹94 Cr, while the operating profit margin (OPM) rose to 42%, indicating effective cost management. Additionally, the company reported a return on equity (ROE) of 13.7% and a return on capital employed (ROCE) of 6.60%, both of which are solid figures that suggest efficient use of shareholder funds and capital. Alembic’s cash conversion cycle (CCC) is notably low at 49 days, indicating effective management of working capital. However, the reported interest coverage ratio (ICR) of 68.23x reflects minimal debt levels, which could limit growth opportunities if external financing is needed.
Balance Sheet Strength and Financial Ratios
The balance sheet of Alembic Ltd is characterized by strength and stability. As of March 2025, total liabilities stood at ₹2,503 Cr, with borrowings reported at a minimal ₹13 Cr, highlighting a strong equity base and low financial leverage. The company’s reserves have increased to ₹2,484 Cr by September 2025, up from ₹2,287 Cr in March 2025, indicating retained earnings and a solid buffer for future investments. The current ratio of 1.85x suggests that Alembic has sufficient short-term assets to cover its liabilities, which is favorable compared to typical industry benchmarks. The price-to-book value (P/BV) ratio stands at 1.08x, slightly above the sector average, suggesting the stock is fairly valued. Alembic’s asset turnover ratio of 0.09% indicates a moderate efficiency in utilizing assets to generate sales, which is an area for potential improvement.
Shareholding Pattern and Investor Confidence
Alembic Ltd’s shareholding structure reveals significant promoter confidence, with promoters holding 70.88% of the equity as of September 2025. This high level of promoter ownership typically signals strong alignment of interests with shareholders. Foreign institutional investors (FIIs) have increased their stake from 0.70% in March 2023 to 1.38% by September 2025, indicating growing confidence from foreign investors in Alembic’s business model. Conversely, domestic institutional investors (DIIs) have a minimal presence, holding only 0.05% of the shares, which suggests a lack of broader institutional support. The total number of shareholders has fluctuated, with a recent count of 1,06,470, showing a slight decline from the peak of 1,07,423 in December 2024. This trend may reflect a cautious sentiment among the public investors, which could impact liquidity and market perception.
Outlook, Risks, and Final Insight
The outlook for Alembic Ltd appears cautiously optimistic, supported by strong revenue growth and profitability metrics. However, risks remain, including the company’s reliance on a limited number of institutional investors and potential fluctuations in the real estate market driven by economic conditions. The low level of debt provides a cushion against financial distress but may limit aggressive expansion plans. Should Alembic maintain its current trajectory, it could leverage its strong balance sheet for strategic acquisitions or investments. Conversely, should market conditions deteriorate or interest rates rise significantly, it may face challenges in sustaining its growth momentum. Overall, Alembic Ltd stands at a pivotal point, where prudent management decisions could harness its strengths while navigating inherent risks in the real estate sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hampton Sky Realty Ltd | 362 Cr. | 13.2 | 32.2/11.7 | 5.03 | 0.00 % | 6.07 % | 3.84 % | 1.00 | |
| Grovy India Ltd | 61.2 Cr. | 45.9 | 58.8/37.0 | 17.5 | 16.5 | 0.22 % | 7.63 % | 9.12 % | 10.0 |
| Gothi Plascon (India) Ltd | 40.8 Cr. | 40.0 | 53.6/37.8 | 23.4 | 12.1 | 5.00 % | 18.8 % | 14.2 % | 10.0 |
| Generic Engineering Construction & Projects Ltd | 250 Cr. | 43.8 | 55.9/22.0 | 20.5 | 50.6 | 0.00 % | 7.55 % | 2.97 % | 5.00 |
| Garnet Construction Ltd | 89.7 Cr. | 64.5 | 77.8/21.6 | 3.48 | 91.8 | 0.00 % | 9.96 % | 7.47 % | 10.0 |
| Industry Average | 16,554.79 Cr | 398.87 | 71.23 | 148.92 | 0.64% | 12.33% | 12.56% | 6.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37 | 31 | 37 | 37 | 32 | 39 | 49 | 51 | 53 | 58 | 60 | 50 | 56 |
| Expenses | 26 | 20 | 24 | 26 | 22 | 28 | 25 | 30 | 33 | 32 | 33 | 30 | 33 |
| Operating Profit | 11 | 10 | 13 | 11 | 10 | 12 | 24 | 20 | 20 | 26 | 27 | 20 | 23 |
| OPM % | 30% | 34% | 36% | 30% | 31% | 30% | 49% | 40% | 37% | 46% | 45% | 39% | 42% |
| Other Income | 59 | 2 | -9 | 3 | 48 | 2 | 2 | 2 | 66 | 4 | 3 | 4 | 65 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 1 | 2 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 68 | 11 | 3 | 12 | 56 | 11 | 24 | 19 | 82 | 27 | 27 | 20 | 85 |
| Tax % | 10% | 2% | -55% | 14% | 8% | 9% | 12% | 10% | 6% | 5% | 12% | 10% | 10% |
| Net Profit | 115 | 46 | 48 | 44 | 91 | 61 | 72 | 56 | 121 | 65 | 68 | 62 | 128 |
| EPS in Rs | 4.49 | 1.78 | 1.88 | 1.73 | 3.53 | 2.39 | 2.81 | 2.17 | 4.71 | 2.55 | 2.67 | 2.40 | 5.00 |
Last Updated: January 2, 2026, 1:34 pm
Below is a detailed analysis of the quarterly data for Alembic Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Jun 2025) to 56.00 Cr., marking an increase of 6.00 Cr..
- For Expenses, as of Sep 2025, the value is 33.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Jun 2025) to 33.00 Cr., marking an increase of 3.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Jun 2025) to 23.00 Cr., marking an increase of 3.00 Cr..
- For OPM %, as of Sep 2025, the value is 42.00%. The value appears strong and on an upward trend. It has increased from 39.00% (Jun 2025) to 42.00%, marking an increase of 3.00%.
- For Other Income, as of Sep 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Jun 2025) to 65.00 Cr., marking an increase of 61.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 85.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Jun 2025) to 85.00 Cr., marking an increase of 65.00 Cr..
- For Tax %, as of Sep 2025, the value is 10.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 10.00%.
- For Net Profit, as of Sep 2025, the value is 128.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Jun 2025) to 128.00 Cr., marking an increase of 66.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.00. The value appears strong and on an upward trend. It has increased from 2.40 (Jun 2025) to 5.00, marking an increase of 2.60.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:41 am
| Metric | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,121 | 144 | 134 | 147 | 125 | 124 | 74 | 74 | 78 | 127 | 157 | 222 | 224 |
| Expenses | 1,018 | 134 | 128 | 140 | 114 | 106 | 71 | 62 | 64 | 87 | 101 | 128 | 127 |
| Operating Profit | 103 | 10 | 6 | 7 | 11 | 18 | 3 | 11 | 14 | 40 | 57 | 94 | 97 |
| OPM % | 9% | 7% | 5% | 5% | 9% | 15% | 4% | 15% | 18% | 32% | 36% | 42% | 43% |
| Other Income | 16 | 21 | 25 | 25 | 37 | 29 | 93 | 10 | 89 | 54 | 55 | 75 | 76 |
| Interest | 32 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 43 | 6 | 6 | 5 | 4 | 3 | 3 | 4 | 5 | 7 | 8 | 11 | 11 |
| Profit before tax | 44 | 23 | 25 | 27 | 44 | 45 | 93 | 17 | 98 | 87 | 103 | 156 | 159 |
| Tax % | 10% | -3% | 2% | -3% | 5% | 8% | 0% | 19% | 12% | 7% | 10% | 7% | |
| Net Profit | 40 | 107 | 235 | 145 | 163 | 213 | 329 | 343 | 222 | 191 | 269 | 311 | 324 |
| EPS in Rs | 1.48 | 3.99 | 8.78 | 5.45 | 6.10 | 8.30 | 12.82 | 13.35 | 8.65 | 7.42 | 10.46 | 12.10 | 12.62 |
| Dividend Payout % | 17% | 4% | 2% | 4% | 3% | 2% | 5% | 2% | 21% | 30% | 23% | 20% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 119.63% | -38.30% | 12.41% | 30.67% | 54.46% | 4.26% | -35.28% | -13.96% | 40.84% | 15.61% |
| Change in YoY Net Profit Growth (%) | 0.00% | -157.92% | 50.71% | 18.26% | 23.79% | -50.20% | -39.53% | 21.31% | 54.80% | -25.22% |
Alembic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 25% |
| 3 Years: | 42% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -1% |
| 3 Years: | 12% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 2% |
| 3 Years: | 13% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| Last Year: | 14% |
Last Updated: September 4, 2025, 10:45 pm
Balance Sheet
Last Updated: December 4, 2025, 12:55 am
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 53 | 53 | 53 | 53 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
| Reserves | 311 | 474 | 750 | 858 | 1,032 | 1,157 | 1,367 | 2,246 | 2,445 | 2,027 | 2,134 | 2,287 | 2,484 |
| Borrowings | 408 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 14 | 13 |
| Other Liabilities | 251 | 91 | 64 | 81 | 73 | 57 | 53 | 112 | 135 | 127 | 134 | 150 | 179 |
| Total Liabilities | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 | 2,727 |
| Fixed Assets | 393 | 169 | 146 | 171 | 179 | 209 | 225 | 265 | 297 | 321 | 369 | 409 | 426 |
| CWIP | 4 | 2 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 1 | 0 | 0 |
| Investments | 8 | 299 | 605 | 732 | 913 | 1,001 | 1,133 | 2,047 | 2,208 | 1,754 | 1,786 | 1,900 | 2,115 |
| Other Assets | 591 | 149 | 124 | 89 | 67 | 55 | 110 | 91 | 127 | 130 | 173 | 194 | 185 |
| Total Assets | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 | 2,727 |
Below is a detailed analysis of the balance sheet data for Alembic Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 51.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 51.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,484.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,287.00 Cr. (Mar 2025) to 2,484.00 Cr., marking an increase of 197.00 Cr..
- For Borrowings, as of Sep 2025, the value is 13.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 14.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 179.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 150.00 Cr. (Mar 2025) to 179.00 Cr., marking an increase of 29.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,727.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,503.00 Cr. (Mar 2025) to 2,727.00 Cr., marking an increase of 224.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 426.00 Cr.. The value appears strong and on an upward trend. It has increased from 409.00 Cr. (Mar 2025) to 426.00 Cr., marking an increase of 17.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 2,115.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,900.00 Cr. (Mar 2025) to 2,115.00 Cr., marking an increase of 215.00 Cr..
- For Other Assets, as of Sep 2025, the value is 185.00 Cr.. The value appears to be declining and may need further review. It has decreased from 194.00 Cr. (Mar 2025) to 185.00 Cr., marking a decrease of 9.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,727.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,503.00 Cr. (Mar 2025) to 2,727.00 Cr., marking an increase of 224.00 Cr..
Notably, the Reserves (2,484.00 Cr.) exceed the Borrowings (13.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -305.00 | 10.00 | -3.00 | 7.00 | 11.00 | 18.00 | 3.00 | 11.00 | 14.00 | 40.00 | 48.00 | 80.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 122 | 76 | 54 | 74 | 40 | 44 | 69 | 71 | 67 | 46 | 49 |
| Inventory Days | 158 | 880 | 659 | 438 | 247 | 289 | 411 | 2,112 | 2,885 | 3,694 | ||
| Days Payable | 128 | 200 | 144 | 128 | 125 | 202 | 151 | 693 | 640 | 1,237 | ||
| Cash Conversion Cycle | 93 | 801 | 591 | 364 | 195 | 126 | 305 | 1,488 | 2,316 | 67 | 2,502 | 49 |
| Working Capital Days | 108 | 235 | 172 | 39 | 20 | 13 | 22 | 97 | 223 | 118 | 77 | 57 |
| ROCE % | 10% | 4% | 4% | 4% | 4% | 7% | 1% | 4% | 4% | 5% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 10,000,000 | 0.39 | 81.35 | 10,000,000 | 2025-04-22 14:12:25 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| Diluted EPS (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| Cash EPS (Rs.) | 6.04 | 3.92 | 3.40 | 3.55 | 0.69 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.07 | 85.11 | 80.93 | 97.23 | 89.45 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.07 | 85.11 | 80.93 | 97.23 | 89.45 |
| Revenue From Operations / Share (Rs.) | 8.64 | 6.13 | 4.96 | 3.05 | 2.86 |
| PBDIT / Share (Rs.) | 6.57 | 4.35 | 4.07 | 4.02 | 0.83 |
| PBIT / Share (Rs.) | 6.15 | 4.04 | 3.81 | 3.83 | 0.67 |
| PBT / Share (Rs.) | 6.06 | 4.00 | 3.38 | 3.81 | 0.66 |
| Net Profit / Share (Rs.) | 5.63 | 3.62 | 3.14 | 3.36 | 0.53 |
| NP After MI And SOA / Share (Rs.) | 12.10 | 10.46 | 7.42 | 8.65 | 13.35 |
| PBDIT Margin (%) | 75.98 | 70.88 | 82.20 | 131.82 | 29.03 |
| PBIT Margin (%) | 71.19 | 65.90 | 76.91 | 125.60 | 23.67 |
| PBT Margin (%) | 70.08 | 65.20 | 68.21 | 125.10 | 23.18 |
| Net Profit Margin (%) | 65.15 | 58.96 | 63.35 | 110.19 | 18.82 |
| NP After MI And SOA Margin (%) | 140.01 | 170.56 | 149.83 | 283.89 | 466.35 |
| Return on Networth / Equity (%) | 13.28 | 12.29 | 9.17 | 8.89 | 14.92 |
| Return on Capital Employeed (%) | 6.60 | 4.63 | 4.61 | 3.83 | 0.74 |
| Return On Assets (%) | 12.41 | 11.53 | 8.64 | 8.43 | 14.23 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.09 | 0.06 | 0.05 | 0.04 | 0.06 |
| Current Ratio (X) | 1.85 | 1.52 | 2.05 | 2.12 | 1.72 |
| Quick Ratio (X) | 0.95 | 0.49 | 0.99 | 0.83 | 0.80 |
| Inventory Turnover Ratio (X) | 2.31 | 0.09 | 0.07 | 0.12 | 0.26 |
| Dividend Payout Ratio (NP) (%) | 19.83 | 21.03 | 24.24 | 2.31 | 4.49 |
| Dividend Payout Ratio (CP) (%) | 19.18 | 20.43 | 23.41 | 2.26 | 4.44 |
| Earning Retention Ratio (%) | 80.17 | 78.97 | 75.76 | 97.69 | 95.51 |
| Cash Earning Retention Ratio (%) | 80.82 | 79.57 | 76.59 | 97.74 | 95.56 |
| Interest Coverage Ratio (X) | 68.23 | 100.70 | 224.79 | 265.00 | 58.96 |
| Interest Coverage Ratio (Post Tax) (X) | 59.51 | 84.77 | 197.06 | 222.52 | 39.24 |
| Enterprise Value (Cr.) | 2539.12 | 2154.92 | 1520.56 | 1855.97 | 2634.71 |
| EV / Net Operating Revenue (X) | 11.44 | 13.68 | 11.95 | 23.73 | 35.84 |
| EV / EBITDA (X) | 15.06 | 19.30 | 14.54 | 18.00 | 123.44 |
| MarketCap / Net Operating Revenue (X) | 11.40 | 13.64 | 11.97 | 23.75 | 35.92 |
| Retention Ratios (%) | 80.16 | 78.96 | 75.75 | 97.68 | 95.50 |
| Price / BV (X) | 1.08 | 0.98 | 0.73 | 0.74 | 1.15 |
| Price / Net Operating Revenue (X) | 11.40 | 13.64 | 11.97 | 23.75 | 35.93 |
| EarningsYield | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 |
After reviewing the key financial ratios for Alembic Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.04. This value is within the healthy range. It has increased from 3.92 (Mar 24) to 6.04, marking an increase of 2.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.07. It has increased from 85.11 (Mar 24) to 91.07, marking an increase of 5.96.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.07. It has increased from 85.11 (Mar 24) to 91.07, marking an increase of 5.96.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 8.64. It has increased from 6.13 (Mar 24) to 8.64, marking an increase of 2.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.57. This value is within the healthy range. It has increased from 4.35 (Mar 24) to 6.57, marking an increase of 2.22.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.15. This value is within the healthy range. It has increased from 4.04 (Mar 24) to 6.15, marking an increase of 2.11.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.06. This value is within the healthy range. It has increased from 4.00 (Mar 24) to 6.06, marking an increase of 2.06.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.63. This value is within the healthy range. It has increased from 3.62 (Mar 24) to 5.63, marking an increase of 2.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.10, marking an increase of 1.64.
- For PBDIT Margin (%), as of Mar 25, the value is 75.98. This value is within the healthy range. It has increased from 70.88 (Mar 24) to 75.98, marking an increase of 5.10.
- For PBIT Margin (%), as of Mar 25, the value is 71.19. This value exceeds the healthy maximum of 20. It has increased from 65.90 (Mar 24) to 71.19, marking an increase of 5.29.
- For PBT Margin (%), as of Mar 25, the value is 70.08. This value is within the healthy range. It has increased from 65.20 (Mar 24) to 70.08, marking an increase of 4.88.
- For Net Profit Margin (%), as of Mar 25, the value is 65.15. This value exceeds the healthy maximum of 10. It has increased from 58.96 (Mar 24) to 65.15, marking an increase of 6.19.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 140.01. This value exceeds the healthy maximum of 20. It has decreased from 170.56 (Mar 24) to 140.01, marking a decrease of 30.55.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.28. This value is below the healthy minimum of 15. It has increased from 12.29 (Mar 24) to 13.28, marking an increase of 0.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.60. This value is below the healthy minimum of 10. It has increased from 4.63 (Mar 24) to 6.60, marking an increase of 1.97.
- For Return On Assets (%), as of Mar 25, the value is 12.41. This value is within the healthy range. It has increased from 11.53 (Mar 24) to 12.41, marking an increase of 0.88.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.09. It has increased from 0.06 (Mar 24) to 0.09, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.52 (Mar 24) to 1.85, marking an increase of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.49 (Mar 24) to 0.95, marking an increase of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 4. It has increased from 0.09 (Mar 24) to 2.31, marking an increase of 2.22.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.83. This value is below the healthy minimum of 20. It has decreased from 21.03 (Mar 24) to 19.83, marking a decrease of 1.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.18. This value is below the healthy minimum of 20. It has decreased from 20.43 (Mar 24) to 19.18, marking a decrease of 1.25.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.17. This value exceeds the healthy maximum of 70. It has increased from 78.97 (Mar 24) to 80.17, marking an increase of 1.20.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.82. This value exceeds the healthy maximum of 70. It has increased from 79.57 (Mar 24) to 80.82, marking an increase of 1.25.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 68.23. This value is within the healthy range. It has decreased from 100.70 (Mar 24) to 68.23, marking a decrease of 32.47.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 59.51. This value is within the healthy range. It has decreased from 84.77 (Mar 24) to 59.51, marking a decrease of 25.26.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,539.12. It has increased from 2,154.92 (Mar 24) to 2,539.12, marking an increase of 384.20.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.44. This value exceeds the healthy maximum of 3. It has decreased from 13.68 (Mar 24) to 11.44, marking a decrease of 2.24.
- For EV / EBITDA (X), as of Mar 25, the value is 15.06. This value exceeds the healthy maximum of 15. It has decreased from 19.30 (Mar 24) to 15.06, marking a decrease of 4.24.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.40. This value exceeds the healthy maximum of 3. It has decreased from 13.64 (Mar 24) to 11.40, marking a decrease of 2.24.
- For Retention Ratios (%), as of Mar 25, the value is 80.16. This value exceeds the healthy maximum of 70. It has increased from 78.96 (Mar 24) to 80.16, marking an increase of 1.20.
- For Price / BV (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.98 (Mar 24) to 1.08, marking an increase of 0.10.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.40. This value exceeds the healthy maximum of 3. It has decreased from 13.64 (Mar 24) to 11.40, marking a decrease of 2.24.
- For EarningsYield, as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alembic Ltd:
- Net Profit Margin: 65.15%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.6% (Industry Average ROCE: 12.33%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.28% (Industry Average ROE: 12.56%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 59.51
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.95
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 7.28 (Industry average Stock P/E: 71.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 65.15%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Realty | Alembic Road, Vadodra Gujarat 390003 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chirayu Amin | Chairman |
| Mrs. Malika Amin | Managing Director & CEO |
| Mrs. Rati Desai | Independent Director |
| Mr. Mayurdhvaj Jadeja | Independent Director |
| Mr. Sanjeev Shah | Independent Director |
| Dr. Girish Hirode | Independent Director |
| Mr. Udit Amin | Director |
| Mr. Jain Parkash | Director |
FAQ
What is the intrinsic value of Alembic Ltd?
Alembic Ltd's intrinsic value (as of 25 January 2026) is ₹87.24 which is 5.07% lower the current market price of ₹91.90, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,360 Cr. market cap, FY2025-2026 high/low of ₹126/85.5, reserves of ₹2,484 Cr, and liabilities of ₹2,727 Cr.
What is the Market Cap of Alembic Ltd?
The Market Cap of Alembic Ltd is 2,360 Cr..
What is the current Stock Price of Alembic Ltd as on 25 January 2026?
The current stock price of Alembic Ltd as on 25 January 2026 is ₹91.9.
What is the High / Low of Alembic Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alembic Ltd stocks is ₹126/85.5.
What is the Stock P/E of Alembic Ltd?
The Stock P/E of Alembic Ltd is 7.28.
What is the Book Value of Alembic Ltd?
The Book Value of Alembic Ltd is 98.8.
What is the Dividend Yield of Alembic Ltd?
The Dividend Yield of Alembic Ltd is 2.61 %.
What is the ROCE of Alembic Ltd?
The ROCE of Alembic Ltd is 6.90 %.
What is the ROE of Alembic Ltd?
The ROE of Alembic Ltd is 13.7 %.
What is the Face Value of Alembic Ltd?
The Face Value of Alembic Ltd is 2.00.